Navigation Links
BD Board Declares Dividend
Date:5/20/2009

FRANKLIN LAKES, N.J., May 20 /PRNewswire-FirstCall/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 33 cents per common share, payable on June 30, 2009 to holders of record on June 9, 2009. The indicated annual dividend rate is $1.32 per share.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

    Contacts:
    Colleen T. White, Corporate Communications - 201-847-5369
    Patricia A. Spinella, Investor Relations - 201-847-5453

'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Recondo Technology Announces Two New Board Members
2. Digirad Names Two Veteran Healthcare Executives to Board
3. Many Companies Preparing on Global Scale for A(H1N1) Swine Flu Pandemic, According to Global Survey by Councils of The Conference Board
4. Support Bristols Highly Qualified Independent Nominees for Advocat Board
5. InfoGroup Founder and Board Member Criticizes Adoption of Poison Pill
6. Joslin Diabetes Center Names Boston Celtics Star Ray Allen to Board of Trustees
7. WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board
8. XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials With the SEC
9. Thoratec Announces Appointment of Paul LaViolette to Board of Directors
10. Martin Crane, M.D., Assumes Chairmanship of the Federation of State Medical Boards
11. Blue Cross Board of Trustees Elects Two New Members

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., SMITHFIELD, R.I., Dec. 1 In ...sumptions are hazardous and can result in injury -...gulation, a handful of persistent bad assumptions ...ss of occupational Hearing Conservation Programs ...white paper from Howard Leight, " Bad Assumptio...
(Date:12/1/2009)...ec. 1 The following is ...l Development: ,, Chairman Kerry, Ranking Membe...honored to be nominated by President Obama to serv... International Development, and I appreciate his c...ry of State Clinton has expressed the conviction t...
(Date:12/1/2009)... 2009. Performing surgical operations without lea...me a reality. This is demonstrated by the recent s... Transluminal Endoscopy Surgery), an innovative su...the body,s natural orifices. The results are all a...r hospital stay and faster recovery. Currently, th...
(Date:12/1/2009)...2009 A Universit de Montral researcher, funded by...iolence and Violence Against Women, has launched a...n men. "We started our research seeking men in the... couldn,t find any," says Simon Louis Lajeunesse, ... of Social Work. , "The objective of my work is...
(Date:12/1/2009)... Global measles deaths drop worldwide, but gains ...er 1, 2009 -- WHAT: Measles Initiative partners...se Control and Prevention, the United Nations Foun...– will announce the latest global health ach..., December 3, 2009 at 10:00 a.m. ET/16:00 CET. Th...
Breaking Medicine News(10 mins):Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3Health News:Are the effects of pornography negligible? 2Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2
... March 26 WPCS International,Incorporated (Nasdaq...rvices,for specialty communication systems and wir...its subsidiaries, it has been awarded approximatel...ion, Yosemite Vista Estates,Colliers International...
... Mich., March 26 GeneGo, Inc., the leading,system...se of MetaMiner,Cystic Fibrosis, a first of its ki... advance drug discovery for cystic fibrosis, a,lif... integrating and analyzing cystic fibrosis data., ...
...SSIA, Pa., March 26 Allied Security Holdings,LLC ...he Company will hold,a conference call with member...l year 2007 results. The conference call is schedu...al callers. In,order to join this conference call,...
...E, Ill., March 26 Lifeway Foods,Inc. (Nasdaq: LW... Lifeway Foods, Inc. Webcast, When: March 3....videonewswire.com/event.asp?id=46717 , How: ...1010. Parties that will be dialing in for this ca...
...senior finance executives globally with an in-dept...India, ISELIN, N.J., March 26 Two separate Ernst...he role of the chief financial,officer (CFO) and f...nization over the past two years, the survey resul...
...Calif., March 25 Grubb & Ellis Healthcare,REIT, I...ls Medical Plaza,in the Cincinnati suburb of Liber...berty Falls Medical Plaza is a two-story,medical o... primarily provided by LaSalle Bank N.A. and KeyBa...
Other Medicine News:Health News:WPCS Announces $12 Million in New Projects 2Health News:GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery 2Health News:GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery 3Health News:Allied Security Holdings LLC to Hold a Conference Call to Discuss Fiscal Year 2007 Results on Thursday, March 27, 2008 at 11:00 AM EDT 2Health News:Webcast Alert: Lifeway Foods, Inc. Announces 2007 Year End Full Financial Results 2Health News:Surveys Find Key Changes in the Role of the Pharmaceutical CFO 2Health News:Surveys Find Key Changes in the Role of the Pharmaceutical CFO 3Health News:Surveys Find Key Changes in the Role of the Pharmaceutical CFO 4Health News:Surveys Find Key Changes in the Role of the Pharmaceutical CFO 5Health News:Grubb & Ellis Healthcare REIT Acquires Liberty Falls Medical Plaza in Liberty Township, Ohio 2Health News:Grubb & Ellis Healthcare REIT Acquires Liberty Falls Medical Plaza in Liberty Township, Ohio 3
(Date:12/1/2009)...ewswire-FirstCall/ -- An expert from PAREXEL Inter...lobal biopharmaceutical services provider, will le...drug development in Asia at the Partnerships in Cl...December 1-3, 2009 at the Intercontinental Hotel i...e, which is focused on maximizing efficiency and m...
(Date:11/30/2009)...0 Microban International, Ltd., th...protection, is pleased to announce their exclusive...e largest U.S. manufacturer and distributor of cer...nching two new lines of ceramic tile with OutStand...pending silver based technology, in order to creat...
(Date:11/30/2009).../ -- Breast-Specific Gamma Imaging (BSGI) has been... for the detection of ductal carcinoma in situ (DC...s a molecular breast imaging technique that can se...er very early stage cancers. According to findings...ological Society of North America (RSNA), BSGI is ...
Breaking Medicine Technology:PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Virus May Affect Survival in Head and Neck Cancer 53302 1Virus May Affect Survival in Head and Neck Cancer 53302 2MedQuist Reports Second Quarter 2009 Results 53297 1MedQuist Reports Second Quarter 2009 Results 53297 2MedQuist Reports Second Quarter 2009 Results 53297 3MedQuist Reports Second Quarter 2009 Results 53297 4MedQuist Reports Second Quarter 2009 Results 53297 5MedQuist Reports Second Quarter 2009 Results 53297 6MedQuist Reports Second Quarter 2009 Results 53297 7MedQuist Reports Second Quarter 2009 Results 53297 8MedQuist Reports Second Quarter 2009 Results 53297 9MedQuist Reports Second Quarter 2009 Results 53297 10Clinical Trial by Licensee Does Not Meet Primary Endpoint 53294 1Clinical Trial by Licensee Does Not Meet Primary Endpoint 53294 2
...ation approved to reduce both A1C and LDL choleste...nc.,announced that the United States Food and Drug...lesevelam HCl) to improve glycemic control,(measur...es mellitus in,combination with metformin, sulfony... with other anti-diabetic agents. Welchol is now t...
...onal Trial Published in CANCER: the Journal of the...SEATTLE, Jan. 22 Cell Therapeutics, Inc.,(CTI) (N...of a phase II,clinical study, published in the jou...immunotherapy (RIT) to chemotherapy for previously...on-Hodgkin,s lymphoma,(NHL) was both well tolerate...
Other Medicine Technology:Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 2Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 3Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 4Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 5Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 6Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 7Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 2Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 3Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 4Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 5
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: